Heparin: Mechanism of Action, Pharmacokinetics, Dosing Considerations, Monitoring, Efficacy, and Safety
- 1 October 1995
- Vol. 108 (4), 258S-275S
- https://doi.org/10.1378/chest.108.4_supplement.258s
Abstract
No abstract availableKeywords
This publication has 219 references indexed in Scilit:
- Standardization of heparin therapy improves efficacyArchives of Internal Medicine, 1992
- Heparin-induced thrombocytopaenia complicated by bilateral adrenal haemorrhageIntensive Care Medicine, 1991
- The Antithrombotic Activity and Pharmacokinetics of Enoxaparine, A Low Molecular Weight Heparin, In Humans Given Single Subcutaneous Doses of 20 to 80 mgThe Journal of Clinical Pharmacology, 1988
- Activation of heparin cofactor II by heparin oligosaccharidesBiochemical and Biophysical Research Communications, 1988
- Role of heparin after intravenous thrombolytic therapy for acute myocardial infarctionThe American Journal of Cardiology, 1987
- Cutaneous reactions secondary to heparin injectionsJournal of the American Academy of Dermatology, 1985
- Structure-activity relationship in heparin: A synthetic pentasaccharide with high affinity for antithrombin III and eliciting high anti-factor Xa activityBiochemical and Biophysical Research Communications, 1983
- Highly active heparin species with multiple binding sites for antithrombinBiochemical and Biophysical Research Communications, 1979
- Anticoagulant activity of heparin: Separation of high‐activity and low‐activity heparin species by affinity chromatography on immobilized antithrombinFEBS Letters, 1976
- EFFICACY OF LOW-DOSE HEPARIN IN PREVENTION OF EXTENSIVE DEEP-VEIN THROMBOSIS IN PATIENTS UNDERGOING TOTAL-HIP REPLACEMENTThe Lancet, 1976